Insider Transactions in Q1 2022 at Fibrogen Inc (FGEN)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2022
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,442
-4.09%
|
$77,304
$12.02 P/Share
|
|
Mar 31
2022
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
4,682
-1.87%
|
$56,184
$12.02 P/Share
|
|
Mar 22
2022
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
655
-0.72%
|
$8,515
$13.31 P/Share
|
|
Mar 07
2022
|
Enrique A Conterno Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,081
-2.27%
|
$84,972
$12.69 P/Share
|
|
Mar 07
2022
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
3,905
-1.53%
|
$46,860
$12.69 P/Share
|
|
Mar 07
2022
|
Thane Wettig CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,706
-1.84%
|
$20,472
$12.69 P/Share
|
|
Mar 01
2022
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
756
-0.48%
|
$9,828
$13.62 P/Share
|
|
Feb 14
2022
|
Enrique A Conterno Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
179,400
+36.5%
|
-
|
|
Feb 14
2022
|
Christine Chung SVP, CHINA OPERATIONS |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+15.03%
|
-
|
|
Feb 14
2022
|
Mark Eisner EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+27.51%
|
-
|
|
Feb 14
2022
|
Juan Graham CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+27.64%
|
-
|
|
Feb 14
2022
|
Thane Wettig CEO |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+32.68%
|
-
|
|
Jan 06
2022
|
Enrique A Conterno Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,536
-1.14%
|
$19,968
$13.93 P/Share
|
|
Jan 03
2022
|
Christine Chung SVP, CHINA OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
5,284
-2.46%
|
$73,976
$14.82 P/Share
|
|
Jan 03
2022
|
Mark Eisner EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,043
-6.7%
|
$98,602
$14.82 P/Share
|